Herpes Virus Infections During Treatment With Etanercept in Juvenile Idiopathic Arthritis

被引：6

作者：

Nicolai, R. ^{[1
]}

Cortis, E. ^{[4
]}

Rava, L. ^{[3
]}

Bracaglia, C. ^{[1
]}

Pardeo, M. ^{[1
]}

Insalaco, A. ^{[1
]}

Buonuomo, P. S. ^{[2
]}

Tozzi, A. E. ^{[3
]}

De Benedetti, F. ^{[1
]}

机构：

[1] Bambino Gesu Pediat Hosp, Dept Pediat Med, IRCCS, Div Rheumatol, Piazza St Onofrio 4, I-00165 Rome, Italy

[2] Bambino Gesu Pediat Hosp, Dept Pediat Med, Ist Ricovero & Cura Carattere Sci, Div Rare Dis, Rome, Italy

[3] Bambino Gesu Pediat Hosp, Div Epidemiol, Ist Ricovero & Cura Carattere Sci, Rome, Italy

[4] Osped Santa Maria Stella, Div Pediat, Orvieto, Italy

来源：

JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY | 2016年 / 5卷 / 01期

关键词：

etanercept; herpes simplex virus; juvenile idiopathic arthritis; varicella zoster virus; RHEUMATOID-ARTHRITIS; SAFETY; EFFICACY; REGISTRY; CHILDREN; THERAPY;

D O I：

10.1093/jpids/piu078

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

Incidence rates for varicella and herpes zoster were similar in patients with juvenile idiopathic arthritis receiving etanercept/methotrexate (n = 85, 184.9 patient-years [PY]) or methotrexate alone (n = 71, 199.4 PY); no complicated varicella or herpes zoster cases were reported; herpes labialis incidence was higher in patients receiving etanercept/methotrexate versus methotrexate alone (0.38 vs 0.24 PY).

引用

页码：76 / 79

页数：4

共 50 条

[41] Comparison of treatment response, remission rate and drug adherence in polyarticular juvenile idiopathic arthritis patients treated with etanercept, adalimumab or tocilizumab
Horneff, Gerd
Klein, Ariane
Klotsche, Jens
Minden, Kirsten
Huppertz, Hans-Iko
Weller-Heinemann, Frank
Kuemmerle-Deschner, Jasmin
Haas, Johannes-Peter
Hospach, Anton
ARTHRITIS RESEARCH & THERAPY, 2016, 18
[42] Clinical trial of etanercept tapering in juvenile idiopathic arthritis during remission
Yubo Cai
Xiaosheng Liu
Wenming Zhang
Jianrong Xu
Lanfang Cao
Rheumatology International, 2013, 33 : 2277 - 2282
[43] Improvement of functional ability in children with juvenile idiopathic arthritis by treatment with etanercept
Halbig, M.
Horneff, G.
RHEUMATOLOGY INTERNATIONAL, 2009, 30 (02) : 229 - 238
[44] Etanercept and uveitis in patients with juvenile idiopathic arthritis
Schmeling, H
Horneff, G
RHEUMATOLOGY, 2005, 44 (08) : 1008 - 1011
[45] Etanercept and urticaria in patients with juvenile idiopathic arthritis
Skyttä, E
Pohjankoski, H
Savolainen, A
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2000, 18 (04) : 533 - +
[46] Prediction of clinical non-response to methotrexate treatment in juvenile idiopathic arthritis
Bulatovic, Maja
Heijstek, Marloes W.
Van Dijkhuizen, E. H. Pieter
Wulffraat, Nico M.
Pluijm, Saskia M. F.
de Jonge, Robert
ANNALS OF THE RHEUMATIC DISEASES, 2012, 71 (09) : 1484 - 1489
[47] Development of Inflammatory Bowel Disease in Patients with Juvenile Idiopathic Arthritis Treated with Etanercept
van Dijken, Trudy D.
Vastert, Sebastiaan J.
Gerloni, Valeria M.
Pontikaki, Irene
Linnemann, Kristina
Girschick, Hermann
Armbrust, Wineke
Minden, Kirsten
Prince, Femke H. M.
Kokke, Freddy T. M.
Nieuwenhuis, Edward E. S.
Horneff, Gerd
Wulffraat, Nico M.
JOURNAL OF RHEUMATOLOGY, 2011, 38 (07) : 1441 - 1446
[48] Improvement of functional ability in children with juvenile idiopathic arthritis by treatment with etanercept
M. Halbig
G. Horneff
Rheumatology International, 2009, 30 : 229 - 238
[49] Challenges in the management of juvenile idiopathic arthritis with etanercept
Pain, Clare E.
McCann, Liza J.
BIOLOGICS-TARGETS & THERAPY, 2009, 3 : 127 - 139
[50] Etanercept in juvenile idiopathic arthritis: Who will benefit?
MH Otten
FHM Prince
W Armbrust
R ten Cate
EPAH Hoppenreijs
M Twilt
Y Koopman-Keemink
SL Gorter
KM Dolman
JF Swart
JM van den Berg
NM Wulffraat
MAJ van Rossum
LWA van Suijlekom-Smit
Pediatric Rheumatology, 9 (Suppl 1)

← 1 2 3 4 5 →